Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Alessandro Aiuti, Valeria Calbi et al.|The Lancet|2022Cited by 286
Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical managementLucia Laugwitz, Samuel Groeschel, Caroline Bergner et al.|European Journal of Paediatric Neurology|2024Cited by 28